Physician profile
Anthony Rizzo
NPI 1245294248
$24,464.29
in general payments reported to CMS, 2019-2025
37 companies · $1,818 in 2025
The $1,818 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,344 · 2020: $2,944 · 2021: $5,829 · 2022: $4,287 · 2023: $6,005 · 2024: $1,237 · 2025: $1,818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,941 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,850 · Travel and Lodging: $1,319 · Consulting Fee: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,940.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,850.00 |
| Travel and Lodging | $1,318.92 |
| Consulting Fee | $950.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,766.82 | 2019-2025 | Supera, Esprit, Emboshield Nav6 |
| Bolton Medical INC | $4,818.81 | 2019-2025 | Treo Abdominal Stent-Graft System |
| Inari Medical, INC. | $1,556.27 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Intuitive Surgical, INC. | $1,028.98 | 2022 | |
| Boston Scientific Corporation | $712.37 | 2019-2025 | General - Vascular Intervention |
| Medtronic, INC. | $707.38 | 2022-2025 | Heli-Fx Endoanchor System, Endurant Iis |
| Penumbra, INC. | $532.39 | 2020-2025 | Indigo System, Penumbra System |
| Medtronic Vascular, INC. | $513.45 | 2019 | |
| Endologix LLC | $483.85 | 2019-2025 | |
| Stryker Corporation | $359.14 | 2021-2025 | Artix Mt, Flowtriever |
| W. L. Gore & Associates, INC. | $316.36 | 2019-2022 | |
| Silk Road Medical, INC. | $306.08 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Vasorum USA INC. | $213.57 | 2022 | |
| Cook Medical LLC | $143.18 | 2022-2023 | Zenith Spiral-Z |
| Cvrx, INC. | $129.62 | 2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argon Medical Devices, INC. | $117.77 | 2019-2021 | |
| Amgen INC. | $96.83 | 2019-2022 | |
| Contego Medical, INC | $91.41 | 2022-2023 | |
| Glaxosmithkline, LLC. | $88.92 | 2024-2025 | Jemperli, Zejula |
| Terumo Medical Corporation | $70.51 | 2022 | |
| Cardiva Medical, INC. | $67.00 | 2020-2023 | Cardiva Vascade 6/7f Vcs |
| E.R. Squibb & Sons, L.L.C. | $50.75 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.45 | 2022 | |
| Surmodics, INC. | $35.12 | 2024-2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Sublime Microcatheter, 018, 200cm, Straight |
| Philips North America LLC | $29.64 | 2022 | |
| Cardiovascular Systems INC. | $24.34 | 2019 | |
| Ekos Corporation | $23.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $23.98 | 2025 | |
| Novo Nordisk INC | $21.33 | 2022 | |
| Merck Sharp & Dohme LLC | $18.14 | 2022 | |
| Shockwave Medical, INC | $16.64 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.47 | 2022 | |
| Angiodynamics, INC. | $13.14 | 2020 | |
| Pfizer INC. | $11.97 | 2019 | |
| Smith+Nephew, INC. | $11.54 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.08 | 2025 | Lifevest |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Rizzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.